HIGHLIGHTS
- who: Deasy Natalia Adriana from the Airlangga, Surabaya, Indonesia of Medicine, Oita University, u2011, Idaigaoka, Hasamau2011machi, Yufu, Oita have published the paper: Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients, in the Journal: (JOURNAL)
- what: In contrast to two previous studies, nausea, vomiting, and diarrhea in the study showed striking statistical differences between the FC-positive group and the FC-negative group . Nonetheless, since the authors did not evaluate SARS-CoV-2 PCR from fecal samples, it is premature to determine whether diarrhea and other gastrointestinal symptoms in this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.